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ABSTRACT
Aim: to examine healthcare professionals’ (HP) perceptions and
experiences in relation to adherence to prophylactic treatment
among young people living with haemophilia (YPH).
Methods: All HPs in four haemophilia centres across England and
Wales were invited to participate, and all HPs who agreed to take
part (n = 6) were interviewed. Interviews were audio-recorded,
transcribed and then analysed using Interpretative
Phenomenological Analysis (IPA).
Results: HPs estimate that generally young people with haemophilia
keep to their treatment regimen well, although they also recognise
that adherence may ﬂuctuate with many patients going through
shorter periods of non-adherence. The increasingly personalised or
ﬂexible approach to prophylaxis makes it harder to assess
adherence. The main themes identiﬁed through IPA included (1)
HPs’ suggest that adherence ﬂuctuates (2) Non-adherence is mainly
driven by lifestyle and developmental, social and family factors, and
(3) Education, HPs’ sensitivity to individual needs, and psychological
and peer support are key facilitators of good adherence.
Conclusion: The increasingly ﬂexible approach to prophylaxis
requires a new way of thinking about, and assessment of,
adherence. More personalised treatment regimen can be more
complicated and may, therefore, lead to accidental non-adherence.
The results of this study with HPs complement those of a previous
qualitative study with patients but place greater emphasis on a
broader perspective on understanding drivers of non-adherence as
well as understanding strategies to improve adherence in the
minority of patients who appear to struggle.
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Haemophilia is an inherited bleeding disorder that is caused by a deﬁciency in one of the
coagulation (blood clotting) factors. Haemophilia A is caused by a deﬁciency in factor VIII
and Haemophilia B is caused by a deﬁciency in factor IX. Haemophilia occurs mostly in
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males, and there are approximately 9400 people with either Haemophilia A or B in the
U.K. (United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) Annual
Report, 2015/2016).
Most young people living with severe haemophilia in the U.K. follow a preventative
treatment regimen (known as prophylaxis), which consists of several intravenous injec-
tions of factor concentrate. Prophylaxis increases the concentration of factor in the
blood, which reduces the risk of joint bleeds and the resulting joint damage (Fischer,
2012; Manco-Johnson et al., 2007), and intracranial and muscle bleeds (Ljung, 2009;
Witmer et al., 2011), whilst also improving quality of life (Richards et al., 2010).
It is crucial that patients keep to their prophylactic treatment regimen, as even low
levels of non-adherence can cause signiﬁcant bleeds (Collins et al., 2009; Hacker, Ger-
aghty, & Manco-Johnson, 2001; Manco-Johnson et al., 2007), and may result in joint
damage leading to poorer physical and emotional wellbeing (Manco-Johnson et al.,
2007; du Treil, Rice, & Leissinger, 2007).
Traditional weight-based prophylaxis regimens are becoming less common as many
patients follow more individualised treatment plans designed around their lifestyle,
planned activities, individual bleeding pattern, condition of their musculoskeletal
system, and measurement of coagulation factor in their blood (Collins, 2012; Fischer,
2012; Makris, 2012; van Os, Troop, Ryder, & Hart, 2018). The ﬁndings from a recent
study (van Os, Troop, Sullivan, & Hart, 2017) with a large U.K. sample of young
people with haemophilia (YPH) on prophylaxis suggest that adherence was good with
most patients keeping to their agreed treatment regimen most of the time (just 18%
had a score that indicated that they were non-adherent a signiﬁcant proportion of the
time). However, it is important to note that measures that assess adherence in haemophilia
(such as the Duncan, Kronenberger, Roberson, & Shapiro, 2010), are based on traditional
approaches to treatment, limiting their utility in the context of increasingly personalised
treatment. A qualitative study carried out as part of the same research programme, which
investigated the lived experiences of YPH (van Os et al., 2018) found that the increasingly
ﬂexible and personalised approach has implications for adherence. This is because it may
lead to confusion around treatment frequency and dosing, which in turn could lead to
accidental non-adherence, which is distinct from both skipping and forgetting. The
current study, also part of the same research programme, adds the perspective of haemo-
philia healthcare professionals (HP). This study aims to investigate HPs’ experiences and
perceptions in relation to adherence to prophylaxis, as well as other self-management
behaviours such as treating bleeds, attending clinic appointments, completing treatment
logs, and avoiding activities that are considered too risky for people with severe haemo-
philia (e.g. contact sports such as rugby and football).
Materials and methods
Interpretative Phenomenological Analysis (IPA)
IPA is a qualitative research approach that aims to oﬀer insights into lived experience and
how participants themselves make sense of their experiences (Smith, 2010). IPA is con-
cerned with exploring personal perceptions or accounts of events or states, rather than
trying to produce objective statements of experiences. However, IPA recognises that
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access to the individual participant’s world is dependent on the researcher making sense of
that other personal world through a process of interpretation. IPA is also strongly idio-
graphic in its approach, with an emphasis on detailed analysis of each unique personal
experience before moving to detailed analysis of other cases.
To ensure that standards in relation to rigour, validity and credibility were met, Yard-
ley’s (2000, 2008) ‘Characteristics of good qualitative research’ were used as the guiding
principles. During the research process there was a particular focus on the transparency
of data presentation, reﬂexivity around the researcher’s own assumptions, and consider-
ation of alternative perspectives.
Recruitment
The number of participants in IPA studies is usually small, to enable a detailed case-by-
case analysis that gives full appreciation to each individual participant’s account (Collins
& Nicholson, 2002; Smith & Osborn, 2003). IPA studies employ a fairly homogenous
sample, allowing comparison of similarities and diﬀerences within a group that has
been deﬁned as similar in relation to the phenomenon being investigated (Reid,
Flowers, & Larkin, 2005). Therefore inclusion criteria for participants in this study
were very speciﬁc, participants had to be HPs involved in the care for YPH (12–25
years) with severe haemophilia who follow a prophylactic treatment regimen. All HPs
who were speciﬁcally involved in the care of YPH in four haemophilia centres across
England and Wales (approximately 5 doctors and 9 nurses) were invited to participate
in this study via email, telephone and in person. Eligible participants included phy-
siotherapists, doctors (Registrar, Consultant, Senior Consultant and Centre Director)
and nurses (across all levels of seniority). All participants who agreed to take part,
and who were available (n = 6) were interviewed. Unfortunately no physiotherapists
were available to take part in the study during the data collection period.
Potential participants were sent an information sheet about the study via email and
encouraged to email the researcher if they were interested in taking part. Potential partici-
pants who did not respond within one month were contacted again via email or telephone.
The researcher then contacted all HPs who had indicated that they would like to partici-
pate to arrange the interview. Informed written consent was obtained on the day of the
interview.
Participants
Participants were 4 haemophilia nurses and 2 haematologists. Please see Table 1 for
details.
Table 1. Participant characteristics.
Participant code Role Sex
HP 1 Nurse Female
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Data collection
IPA studies require data collection methods that will result in rich, detailed and ﬁrst-
person accounts of the experiences and or phenomena under investigation. Semi-struc-
tured interviews are considered a good data collection method for IPA studies, as they
facilitate a more informal and free-ﬂow interview, which enables the researcher to
follow cues from participants and probe areas of interest that appear particularly relevant
to each participant’s experiences (Brocki & Wearden, 2006).
A semi-structured discussion guide was developed based on literature in relation to
treatment adherence among young people diagnosed with chronic health conditions
(Alvin, Rey, & Frappier, 1995; Arias Llorente, Bousoño García, & Díaz Martín, 2008; Ian-
notti et al., 2006; La Greca et al., 1995; La Greca & Bearman, 2002; Salema, Elliott, & Gla-
zebrook, 2011; Shaw, 2001), HP involvement in relation to adherence (DiMatteo et al.,
1993; Street, Makoul, Arora, & Epstein, 2009), haemophilia (De Moerloose, Urbancik,
van den Berg, & Richards, 2008; Duncan et al., 2010; Khair, 2013; Llewellyn, Miners,
Lee, Harrington, & Weinman, 2003; Thornburg, 2008; du Treil et al., 2007), and guidance
from Smith and Osborn (2008). Feedback collected from focus groups with patients,
parents, and HPs was used to ﬁne-tune the discussion guide. All interviews were under-
taken by the same interviewer as part of their Ph.D. project, and took place in private
rooms in the haemophilia centres. Participants were not on duty and were, therefore,
able to focus their attention solely on the interview. Questions were delivered in a non-
directive and open style to encourage participants to share their experiences in their
own words. Participants were reassured that information given would be conﬁdential.
At the start of the interview, participants were invited to talk about their experience of
working in the haemophilia centre (e.g. ‘Tell me about what an average day is like for you
in the treatment centre’). To gain further insights HPs were invited to describe their
experiences and perceptions in relation to prophylaxis, and adherence to this treatment
by adolescent and young adult patients (‘How well do your patients adhere to their pro-
phylaxis?’ ‘Tell me about your experiences with non-adherent patients’. ‘In your experi-
ence what kinds of things might interfere with adherence?’ etc.). Lastly, HPs were
encouraged to talk about potential (healthcare) improvements they felt may help them
and/or their patients to improve adherence (‘What would help you to improve adherence?’
etc.). The order in which the above subjects were discussed was ﬂexible, and driven by par-
ticipants themselves. In most of the interview, the HPs volunteered much of the infor-
mation they shared without being prompted or asked speciﬁc questions. Interviews
lasted between 35 and 95 minutes and were audio-recorded, transcribed and analysed fol-
lowing IPA principles and guidelines (Smith, 2003; Smith & Osborn, 2008).
Data analysis
During the analytical process in IPA studies, the researcher engages in a double hermeneu-
tic (Smith, Flowers, & Larkin, 2009), to try and make sense of the participant attempting to
make sense of their experiences.
The transcription of the interview recordings is often seen as the ﬁrst phase of analysis
in IPA studies. Firstly an ‘everything audible’ version was produced to ensure that future
transcriptions stemmed from the maximum possible transcribed content. After removing
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all irrelevant noises and identifying information, validation was carried out by an indepen-
dent researcher who read transcripts while listening to the recordings. The main
researcher then re-read the transcripts to ensure they were ready for analysis.
As suggested by Smith and Osborn (2003) IPA was conducted on a single interview in
its entirety ﬁrst before the remainder of the transcripts were taken through the analytical
process. The analysis started by making comments and annotations (in Nvivo) while
reading and re-reading the transcript. After detailed review, the coding was then
reﬁned, and the Nvivo coded transcript was then exported into an Excel spreadsheet.
This spreadsheet contained one line for each code, and columns providing more infor-
mation about the code (e.g. code name, example quote, notes/reﬂections, and themes to
which the code may belong). The themes were then reviewed with the aim to identify over-
arching themes, which were reported in an additional column. The researcher continually
returned to the transcripts throughout this process, to ensure that the themes and super-
ordinate themes were closely connected to what participants had actually said during the
interviews. Finally, the overarching themes were reﬁned and presented in a table together
with each of their subordinate themes. An independent researcher with no prior knowl-
edge of haemophilia or treatment adherence then reviewed these themes, and their
relation to the initial transcript and each other. This process highlighted certain areas
in the analysis that required attention to ensure that the reporting of the results would
be clear and transparent.
Ethics statement
Ethical approval was obtained from the NHS National Research Ethics Service Committee,
London – City Road & Hampstead (NRES, Ref: 12/LO/2030). This approval covers both
providers and patients.
Results
Superordinate and subordinate themes
Here we present three superordinate themes in relation to HPs perceptions and experi-
ences of adherence to prophylaxis among their adolescent and young adult patients.
Table 2 presents the superordinate themes with their related subordinate themes, and
for which participants each of the themes was relevant.
Theme 1: healthcare professionals suggest that adherence ﬂuctuates
HPs commented on adherence mostly in terms of patients keeping to their agreed treat-
ment regimen, but also in relation to other self-care behaviours such as treating bleeds,
logging treatments and attending clinical appointments. Their patients’ adherence, par-
ticularly in relation to prophylaxis, appears to be one of their key concerns. HPs suggested
that they focus a signiﬁcant proportion of their working week on adherence, e.g. by follow-
ing up individual patients, checking Haemtrack treatment logs, and having face-to-face
meetings with patients. Although adherence is a concern across the patient population,
HPs are particularly concerned about younger patients who are in the pre-adolescent
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and adolescent period, as adherence appears a particular problem during this developmen-
tal stage.
Although HPs found it diﬃcult to estimate adherence to treatment in terms of percen-
tages, they agreed that adherence is generally good for the majority of their patients. Good
in this context means that patients keep to their treatment regimen most of the time, dra-
matically reducing the risk of bleeding.
Gosh, quite hard to think of [laughs] I don’t know if I could put a percentage. But I would say
that the vast majority are actually quite adherent. I’d say the vast – I don’t know, it’s kind of
[pause] 75%. I don’t know, it’s kind of a random number, but I’d say – or even maybe more. I
think, the bulk are more or less fairly adherent. (HP1)
However, HPs explained that a minority of patients struggle with their treatment and that
even patients who tend to keep to their treatment regimen can go through periods of non-
adherence. HPs, in particular nurses, explained that they spend a lot of their time and
eﬀort on this relatively small group of non-adherent patients, either to work with them
to improve their adherence or to treat them for bleeds that are the result of their non-
adherence. Having to concentrate on these non-adherent patients can be diﬃcult for
the haemophilia team, as they often feel their eﬀorts do not necessarily result in better
adherence or fewer bleeds. This sometimes leaves HPs feeling frustrated and worried
about patients who continue to be non-adherent, but also concerned that they do not
have enough time to look after their other patients.
Three HPs estimated adherence among YPH in terms of percentages. They estimated
that although nearly all (90–100%) of their patients take their prophylaxis, signiﬁcantly
fewer patients (50%; 70% and 80% respectively) take it at the agreed time. They suggest
that most non-adherence is about the timing of treatment, with patients taking their pro-
phylaxis in the afternoon or evening instead of the morning. Patients who do not take their
Table 2. Superordinate and subordinate themes for each participant.
Superordinate themes Subordinate themes Participants
1 2 3 4 5 6
Healthcare professionals suggest that adherence
ﬂuctuates
Adherence ﬂuctuates x x x x x
Timing of injections x x x x x
Variability of symptoms
(bleeds)
x x x x x
Haemtrack and
adherence
x x x x x
Non-adherence is mainly driven by lifestyle and
developmental, social and family factors
Lifestyle and time
management
x x x x x x
Venepuncture issues x x x x
Not wanting to be
diﬀerent
x x x x x
Absence of symptoms x x x x
Family and social issues x x x x
Education, HPs’ sensitivity to individual needs, and
psychological and peer support are key facilitators for
good adherence
Education x x x x x x
Psychological support x x x x x x
Peer support x x x x x x
Being sensitive to
individual needs
x x x x x x
Regular contact and
continuity of staﬀ
x x x x x
Collaboration with
schools and community
x x x x
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treatment in the morning may not be adequately protected during the day, when they are
most likely to be at risk of bleeding. HPs speak to patients about the importance of timing
regularly, and try to work with patients to ﬁnd a way to ﬁt treatment in. However, it
appears that some patients are simply not able or willing to consider taking their prophy-
laxis before they leave the house in the morning. This can leave HPs feel powerless, as they
feel there is nothing they can do to get these patients back on track with their treatment.
HPs explained that in recent years patients have increasingly been encouraged to tailor
their treatment around their activities and lifestyle, meaning that treatment plans have
become less regimented. Particularly patients who live an active lifestyle may change
their treatment according to their physical activities, to ensure they are protected at the
times that they are at most risk. It is therefore not always straightforward to ascertain
or deﬁne whether someone is adherent. In some cases, one may argue that someone
who follows a rigid three times per week regimen is non-adherent because they do not
tailor their treatment to provide cover for activities.
So even though they are adhering to their regimen, actually they are sort of non-adherent
because they are not managing around their activity. Or treating at the wrong time. (HP3)
HPs estimated that adherence to the other self-management behaviours is much lower and
more likely to ﬂuctuate over time. They felt that most patients will usually prioritise taking
their prophylaxis because they recognise how important it is, but that completing the
treatment log and attending clinic appointments are not usually prioritised in the same
way. HPs expressed concern about patients who do not treat bleeds appropriately, as
these bleeds often last longer and cause more damage. They felt that patients who
present late with bleeds, or do not treat bleeds adequately, are often also those who struggle
to keep to their treatment regimen, are less likely to log treatments on Haemtrack, or
attend clinic appointments.
When talking about their experiences and perceptions in relation to adherence HPs
clearly felt that they need to follow a more pragmatic approach, and accept that not all
YPH will be able to follow their recommended regimen at all times. HPs tend to work
with patients and/or families to ﬁnd compromises that balance a reduction in treatment
burden with making sure that the patient is still protected, particularly during times
that they are at higher risk of bleeding.
So although there’s lots of positives of daily treatment and that would be ideal in terms of
levels. The practicality of that for some families is that it’s not going to work. I suppose
the compromise then is alternate days or we say “Monday, Wednesday and Friday and
once at the weekend”. If that’s what’s prescribed, I would say 90–100% of people are
doing that. I would say particularly in children that less than 50% of them would be doing
it in the morning. I think it’s after school, in the evening. I suppose it should be like brushing
your teeth that you shouldn’t do something without it, but that’s not how it works for the
families. (HP6)
Not all HPs agreed that bleeds necessarily indicate non-adherence. Some felt that patients
who suﬀer frequent bleeds and those who stop attending clinic appointments are more
likely to be non-adherent. However, others pointed out that there are patients who
keep to their regimen religiously but still suﬀer frequent bleeds because the dosage or fre-
quency of their treatment is not suﬃcient or due to existing joint damage or other factors
that may cause bleeding.
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HPs explained that the majority of patients who follow a prophylactic regimen are
required to log each treatment on Haemtrack, a national, online treatment log. Haemtrack
allows haemophilia centres to monitor patients remotely, to check whether they are taking
their treatment as agreed and whether they are experiencing any bleeds. HPs felt that
information logged on Haemtrack can be a good conversation starter with patients, and
can help to illustrate the link between missed treatments (non-adherence) and bleeds.
I think Haemtrack is quite good because it’s quite nice, not to check up on people but because
it starts the conversation and it makes them actually talk about it and you can say, “Okay, well
why you are missing it, is there things we can do to help” (HP4)
One concern about Haemtrack that was highlighted by several HP is that it is 100% reliant
on the accuracy of information entered by patients. For instance, patients who do not want
to admit that a bleed was caused by an activity they should not have been doing, may log
these bleeds as breakthrough (spontaneous) bleeds. One HP felt that Haemtrack could,
therefore, be used by commissioners to prove that prophylaxis does not work, as patients
should not be having spontaneous bleeds while on prophylaxis. Another concern high-
lighted was that many patients appear to complete the log periodically, typically once a
week or month, rather than after each treatment. This means that the data is not as infor-
mative or useful, particularly as many patients do not appear to complete/change the time
they took each treatment, making it impossible to link bleeds to non-adherence.
Theme 2: non-adherence is mainly driven by lifestyle and developmental, social
and family factors
HPs felt that for many patients adherence to prophylaxis is a question of time and lifestyle.
They showed a strong appreciation of the diﬃculties their patients face in trying to keep to
their prophylactic regime during a busy period, or while going through a signiﬁcant life
event or change. HPs agreed that one of the most challenging aspects of prophylaxis is
the timing of the injections. Although for many patients it would be best to take treatment
in the morning before leaving home, HPs agreed that this is simply not achievable for all
their patients.
I think that that’s also why it’s really important that we visit families at home because that
gives you a much better reality of what family life is like for them. Families maybe where
there’s single parents, there’s multiple children, that in the mornings before school is a
rubbish time. As the health professional and the expert we’re saying “This is what you
should be doing” but the reality of that happening is really, really diﬃcult in terms of prac-
tical. (HP6)
Other issues that were suggested to be potential barriers to adherence include needle
phobia, problems with venous access, YPH not wanting to be diﬀerent from their peers,
social and family issues, and an absence of symptoms making it diﬃcult to understand
the importance of taking prophylaxis.
HPs felt that they have a good range of tools available to support patients while learning
to do their own treatment (e.g. implantable venous access devices, anaesthetic creams, dis-
traction techniques, support from play therapists, peer support, etc.). Thanks to these tools
most patients learn to do their injections without developing needle phobia. However,
several HPs felt quite strongly that the way parents deal with haemophilia and the
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treatment has a strong inﬂuence and that issues such as needle phobia are much more
likely to occur if parents struggle with needles or are anxious about treatment.
Sometimes I think it’s aﬀected by how the parents react to it and how they’re feeling about it.
We do have play specialists, distraction, and we have local anaesthetic creams. If all of those
things are in place in the beginning, what you see then in the centre is that we have boys that
are three or four that will come in and accept it and it all happens really smoothly. Now that
didn’t happen without some other things happening before it. But I think it’s more perhaps
the parents struggle with a bit of needle phobia. And is that needle phobia or the thought of
doing something so invasive to your child (HP6)
HPs explained that for some patients it is very hard to ﬁnd a vein to inject to. These venous
access issues can, in turn, cause treatment-related stress and anxiety, which is likely to
aﬀect adherence as patients may skip treatments when they are feeling anxious or are
struggling to ﬁnd a vein.
HPs suggested that most adolescent patients go through a stage of suboptimal adher-
ence, ranging from occasional skipping to complete disengagement with treatment and
the haemophilia team. They felt that this is partially because many adolescent patients
feel that their haemophilia makes them diﬀerent from their peers, which can cause resent-
ment or embarrassment about having to take treatment.
Don’t like to be diﬀerent, don’t like to be seen diﬀerent. Don’t want to do it, had enough of it,
don’t want to stick needles in themselves, no one else to stick needles in them, feel well in
themselves, a desire to conform with peers. (HP5)
Adolescence is also a time during which many patients take over responsibility for their
own treatment with less or little involvement from their parents. HPs ﬁnd it very challen-
ging to engage with patients while they go through this period, as patients tend to rebel
against the haemophilia team as well as their parents. They clearly felt frustrated that
they do not always have the knowledge or the resources to support these patients
through this challenging period and help them stay on track with their prophylaxis to
prevent bleeds and the related issues.
HPs explained that thanks to prophylaxis many patients now manage to get to adoles-
cence without having experienced any severe bleeds, which makes it diﬃcult for them to
understand why they need to take their prophylaxis. They felt that the experience of a ﬁrst
serious bleed often encourages these non-adherent young patients to start taking their pro-
phylaxis again. However, they also explained that for some patients this only works for a
short period after which they stop taking treatment again, with more bleeds as a result.
This vicious circle is often frustrating and worrying for HPs who look after these patients,
particularly as they often feel there is not much they can do.
The relationship between patients and their parents and siblings was put forward as
another key factor that inﬂuences adherence. HPs spend a signiﬁcant proportion of
their time and resources on helping patients who struggle with their treatment due to
social and family issues.
And we’ve got another family where we have to do supervised prophylaxis for diﬀerent
reasons ‘cos their lives are crazy chaotic and they have huge dogs, like really big dogs in
the house and there’s nowhere safe to actually… These dogs are quite aggressive so there’s
no way you’d want anyone using a needle near a child with all this going on. So they
come to the unit and get to the prophylaxis. (HP4)
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It is clear that HPs are sensitive to individual circumstances, and appreciate that looking
after a child with haemophilia can be stressful for both parents and healthcare pro-
fessionals. HPs felt it is not always clear to them whether haemophilia itself is the cause
of parental stress or anxiety, or whether stress or anxiety caused by outside factors
make it harder to manage haemophilia for parents.
Theme 3: education, HPs’ sensitivity to individual needs, and psychological and
peer support are key facilitators for good adherence
Factors that facilitate adherence among YPH, according to HPs, include sensitivity to indi-
vidual needs of parents and patients, psychosocial support, peer support and support for
parents. HPs felt that patients’ knowledge and understanding about haemophilia and how
prophylaxis works are crucial, as patients who are more aware tend to be more adherent.
They, therefore, felt that education to improve patient and parental knowledge and under-
standing may help to improve adherence. Several interviewees emphasised that they felt
that it is important to involve patients from an early age so that they can learn to do
their treatment themselves gradually before they start secondary school.
The norm would be persuasion I think and gradual involvement of the child, and we do make
it quite clear to the boys when they start on prophylaxis, when they’re going through prophy-
laxis in primary school, that the aim is that by the time they go to secondary school they’ll be
giving their own treatment […] we encourage boys to start helping the parents at home,
mixing up treatment, cleaning the skin, take needles out after ﬁnishing treatment, you
know doing everything other than venepuncture. And then school holidays we try and get
them to come to the unit so I guess depending on how they’re doing but certainly from
the age of nine they’d be coming to the unit to try and learn some venepuncture (HP5)
HPs agreed that starting early also ensures that patients are used to doing their own treat-
ment before they hit adolescence, which is a period during which they ﬁnd it generally
harder to engage patients. HPs felt that it is important to recognise that they are not
necessarily trained to educate or provide psychosocial/emotional support and often do
not have suﬃcient time or resources to work with patients or families who are struggling.
HPs talked about situations in which they found it challenging to ascertain the exact
nature of the issues that were aﬀecting their patient, and felt that they could have done
with help from specialist support staﬀ.
if they were in-house it maybe they would be able to build it as part of the relationship with
the centre in a more holistic sort of way— but I think there is a lot of psychosocial bits that as
nurses we try to do our best but it would be nice if we had somebody who was a professional
who knew how to deal, especially with, because some of them have some pretty major issues
that, that, you know, sometimes I think we feel a bit lost with how to really deal with properly
and support (HP1)
HPs suggested that particularly support from a play therapist, psychologist, or social
worker can be helpful when working with a patient or family who are struggling with pro-
phylaxis. Play therapists tend to work with younger children to, for instance, remove some
of the anxiety that is attached to their hospital visits and treatment. Social workers may
work with families on some of the social or relational barriers that interfere with treat-
ment, whereas a psychologist may tackle issues around needle phobia and emotional or
mental health issues that could impact on adherence. Although each of the above
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specialists have their own area of expertise, in reality it is unlikely that haemophilia centres
have access to a play specialist, social worker and psychologist. It is therefore likely that
these specialists work with patients and families in ﬂexible ways that ‘borrow’ techniques
from the other specialisms if and when needed.
The way in which support from psychosocial specialists is accessed appears to diﬀer
from centre to centre. Two HPs explained that they have access to a play specialist that
is based at their hospital and that their team includes at least one psychologist and/or
social worker who can identify psychosocial issues as they arise and work with patients
before problems escalate.
I think it helps me sometimes because they’re looking from the outside, I’m involved in the
moment, they’re just kind of observing what’s happening and then they can oﬀer some
diﬀerent advice. We’ve done lots since we had psychology embedded in our service, so
there’s families with children that are new to haemophilia so a new diagnosis, we do some
joint work (HP6)
These HPs also described how they themselves felt psychologically or emotionally sup-
ported by the psychologist or social worker, helping them to deal with diﬃcult situations
and the stress involved in looking after people with haemophilia.
HPs from other centres explained that patients have to be referred to psychosocial ser-
vices that are provided by a separate team within the hospital, an associated hospital or in
the community. They felt frustrated and concerned for patients who often struggled to
access support services.
You would try and refer for psychological support but we don’t actually have anything within
the unit and we don’t have anything to access. We’ve had a real diﬃculty with a patient who
really does need some long-term therapy, and we don’t have that. We have it for patients with
HIV or hepatitis and trying to get that in the community is very diﬃcult and very challen-
ging, they don’t have the resources and it’s so frustrating ‘cos you can see that he needs it and
he wants it (HP4)
Most of the HPs felt that a multidisciplinary team that has access to play a therapist and
social worker, but includes a psychologist on a permanent basis is the ideal set-up. This
would mean that patients would see the psychologist as part of the team and the threshold
to access support would, therefore, be low. Rather than patients having to see a psychol-
ogist separately once potential issues arise, an in-house psychologist may be able to ident-
ify issues early and support patients and their families through challenging periods
without the need for signiﬁcant psychological interventions.
Whereas I think if we had access to someone most of the time or a lot of the time so this
person’s not a complete alien to these patients […] I can’t help but think that some of the
problems that you do see these patients going through could be nipped in the bud. You
wouldn’t get so bad that you’re having to refer them to a counsellor, it’s something that
might have been able to have been dealt with before it became a big problem. (HP2)
In addition to psychological support, HPs felt that peer support groups or activities can be
very beneﬁcial. Some haemophilia centres facilitate meetings between young patients to
provide social support as well as facilitating patients to learn from each other. Two HPs
explained that they occasionally bring together non-adherent patients with adherent
patients to try and encourage non-adherent patients to get back on track with their
treatment.
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I think it went very well because the one who didn’t treat was able to see someone of the same
age, and see how he managed to do it himself. And he showed him – and the other boy who
didn’t treat himself was able to actually do it himself and it’s given him conﬁdence because he
didn’t seem like the most – one child was quite a conﬁdent child and the other one was not
such a conﬁdent personality and I think it was good for them and I believe they even
exchanged numbers. It just gives them a chance to meet someone else with the same con-
dition. (HP3)
However, HPs appeared frustrated that the current pressures on budgets and resources
have made it harder and sometimes impossible to organise regular groups or activities
locally.
In the context of the more ﬂexible approach to prophylaxis, HPs emphasised that per-
sonalising care is not just about treatment, but also about the way you approach a patient
and communicate with them. HPs try and tailor their approach to individual patients as
much as possible by, for instance, providing telephone appointments to accommodate
people who work long hours or contacting patients in their preferred way (e.g. email,
text or telephone), but also by being mindful of any personal issues the patient has and
the tone and language they use. Although prophylaxis is the treatment of choice, HPs
appreciate that for some patients it is simply not possible to follow a prophylactic
regimen. They often try a range of diﬀerent strategies that take the individual patient’s cir-
cumstances into account, but sometimes have to accept that a patient does not want to
take prophylaxis. In those cases, they shift their focus to making sure that the patient
does not disengage completely, and sometimes this means that a patient is moved to an
on-demand regimen to treat bleeds if and when they occur. In other cases, they may
reach a compromise with a patient or family that reduces the treatment burden while
still providing some prophylactic cover.
So although there’s lots of positives of daily treatment and that would be ideal in terms of
levels. The practicality of that for some families is that it’s not going to work. I suppose
the compromise then is alternate days or we say “Monday, Wednesday and Friday and
once at the weekend’’. If that’s what’s prescribed, I would say 90–100% of people are
doing that. I would say particularly in children that less than 50% of them would be doing
it in the morning. I think it’s after school, in the evening. (HP6)
HPs appear passionate about supporting their patients and believe that a good relationship
between patients and the haemophilia team can be crucial in keeping patients on track.
HPs felt that maintaining a good relationship with patients used to be more straightfor-
ward, as patients had to come to the haemophilia centre frequently to receive treatment,
or to pick up their home treatment. These visits oﬀered an opportunity to catch patients
for an informal chat and enabled the team to identify potential issues quickly. Now that
many patients get their treatment delivered to their home, contact has become less fre-
quent, with some patients only coming to the haemophilia centre once or twice a year.
HPs felt that as a result, some patients may become less engaged with the haemophilia
team and their treatment, potentially leading to non-adherence. They explained that
when contact with a patient breaks down (i.e. when they do not attend clinic appointments
or do not answer telephone calls or letters from the haemophilia centre) it can be an indi-
cation that the patient is not keeping to their treatment regimen and not treating bleeds
appropriately. It can be very challenging and sometimes frustrating to try and re-
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engage these patients. HPs explained that they tend to spend a lot of time and eﬀort trying
to contact and chase patients that they are concerned about.
They agreed that this tends to be a small group of patients who take up a disproportion-
ate amount of time because they often do not respond to letters or telephone calls and
require regular follow-ups. When this signiﬁcant eﬀort does not result in better adherence
(resulting in more regular bleeds) this can be frustrating for HPs who care about their
patients and are genuinely worried when a patient goes ‘oﬀ radar’. In particular, nurses
felt that they support patients in many more ways than speciﬁed in their job description.
They appear to go above and beyond to help and support patients. HPs suggested that staﬀ
turnover is low in haemophilia centres, and that as a result the haemophilia team and
patients get to know each other well, and often develop a close relationship. Visiting
families at home can help with establishing a good relationship, and identifying potential
issues that would be diﬃcult to ascertain in clinic.
But I think once you start actually going and seeing them outside the hospital it gives you a
completely diﬀerent dynamic on things and them you, and sometimes it becomes a lot more
personal and you are more involved in their lives, you’re more involved because you’re
watching them grow-up and they know you, which is nice and it helps to some extent
because they’ve got a better trust and a better bond with you. (HP2)
Although the close relationships between the haemophilia team and their patients was
generally seen as positive, it was also recognised that it can lead to over-dependency on
a speciﬁc nurse or doctor. One nurse explained that she regularly gets contacted on her
personal mobile phone by patients, another joked that nurses do not need to say their
name when they answer the phone as patients immediately recognise their voices.
In addition to working with patients and their families directly, haemophilia teams try
to engage and collaborate with schools and community teams as much as possible. Schools
are an important priority, as young patients spend a signiﬁcant amount of time at school
and may take part in potentially risky activities, such as PE lessons. HPs explained that
they also try to educate schools about what haemophilia is, and what it means for the
patient and their family, to encourage schools to focus on supporting the patient rather
than just managing the risks.
Discussion
Findings
HPs felt that adherence among YPH is generally good, although they explained that levels
of adherence are likely to ﬂuctuate, with even very adherent patients experiencing short
periods of non-adherence. As prophylactic regimen are increasingly personalised and
ﬂexible, it is much harder to ascertain if a patient is non-adherent. In addition to the exist-
ing designations of non-adherence due to forgetting and skipping, with a personalised
regimen it is also possible to be non-adherent accidentally. In many cases, haemophilia
teams only intervene if a patient is presenting with bleeds or not attending check-up
appointments, as they are often an indication that someone is not engaged with their treat-
ment, and may be struggling with self-management.
Time management and lifestyle-related issues were suggested to be key reasons why
patients do not adhere to their treatment. During a busy time, or signiﬁcant life event
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or change, someone is less likely to adhere. Most HPs agreed with the existing literature
(e.g. Breakey, Blanchette, & Bolton-Maggs, 2010; Schrijvers, Schuurmans, & Fischer,
2016; Thornburg, 2008) that adherence may be a particular issue during adolescence, as
a result of the speciﬁc developmental issues that characterise this period. It can be challen-
ging for haemophilia teams to engage with adolescent patients, particularly if they rebel
against the haemophilia team and parents. Other reasons for non-adherence that were
mentioned were issues related to venous access; absence of symptoms; family dynamics
(relationship with and support from parents and siblings); psychosocial issues; and a
lack of knowledge about haemophilia and treatment.
HPs felt that a multidisciplinary team that, ideally, includes a psychologist and/or social
worker would be the ideal set-up to support patients (and families) who are struggling with
prophylaxis. However, in most haemophilia centres psychosocial support is only available
through referral to a psychologist, which is often diﬃcult due to a lack of funding and
resources. Participants also felt that bringing YPH together through peer support groups
or activities is beneﬁcial, but that the current pressures on budgets and resources have
made it harder and sometimes impossible to organise support groups or activities locally.
It is clear that HPs are passionate about supporting patients in as many ways as they
can, and motivated to keep patients on track with their treatment to ensure optimal
health outcomes. HPs believe that a good relationship between patients and the haemo-
philia team can be crucial in keeping patients on track. They tend to spend a lot of
time and eﬀort trying to contact and chase patients that they are concerned about, and
agreed that this tends to be a small group of patients who take up a disproportionate
amount of time. Their work is made challenging by pressures on resources, patients’
social and psychological issues, and limited understanding of haemophilia within and
outside of the medical profession. However, it appears that they manage to maintain
their motivation to do their best, which is very clearly appreciated by patients (van Os
et al., 2018).
Strengths and limitations
The strength of this qualitative study is that it recruited from four centres across England
and Wales. The ﬁndings represent views of a range of HPs, who are likely to have a range
of experiences and perceptions in relation to haemophilia and prophylaxis.
The most important limitation is that the interview data represent the lived experience
of individual participants, which are not necessarily representative of the whole popu-
lation. It is also impossible to know whether the lived experiences represented in interview
data remain unchanged over time as individual circumstances, experiences and percep-
tions may ﬂuctuate or change.
Implications
Notwithstanding the limitation discussed above, the ﬁndings of this study have a number
of implications. The ﬁndings support previous quantitative evidence that adherence is
generally good amongst YPH (van Os et al., 2018). However, the ﬁndings on the experi-
ence of HPs in the present study also complement the experience of patients reported in
van Os et al. (2018). For example, while patients identiﬁed barriers and facilitators of
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adherence (such as anxiety and inconvenience versus treatment being a routine), HPs
identiﬁed broader drivers of non-adherence such as absence of symptoms and family/
social issues. In addition, while patients identiﬁed the importance of support from
family, friends and haemophilia centres, HPs identiﬁed factors that would improve adher-
ence more broadly, including organisational factors (psychological services, continuity of
haemophilia staﬀ), community factors (e.g. involvement of schools), peer support and HPs
being sensitive to individual needs. Furthermore, while patients identiﬁed the tension
between good self-management and living the life they want, HPs identiﬁed, for
example, the ﬂuctuating nature of adherence and the role of treatment logs to instigate
a conversation about adherence.
Haemophilia teams tend to have good relationships with many of their patients. These
relationships are often maintained by regular contact, particularly with those patients who
are struggling. In the current economic climate, and in the context of reorganisation and
rationalisation of the NHS, this model of care may come under increased pressure and
may not be able continue if resources are cut. However, the ﬁndings from this study
provide evidence for the beneﬁts of the current approach in managing patients with
severe haemophilia, and may, therefore, help haemophilia centres to build a case to
retain their current level of resource.
Many patients require, and indeed access, additional support to help them with the
psychological and social impact of haemophilia. All HPs agreed that psychological
support is an important element of the comprehensive care that many haemophilia
patients require. They felt that this support should ideally be provided within the haemo-
philia centre setting so that the threshold to access this support is low and psychologists
are able to work with patients pro-actively to address issues before they escalate. HPs felt
strongly that regular psychological input would contribute towards better patient out-
comes, particularly for patients who struggle or are disengaged from their treatment.
However, several of the centres involved in this research no longer have (or never had)
a psychologist embedded in their team. The ﬁndings of this research may help centres
to put forward an argument to improve access to psychological support, or indeed
appoint a psychologist in their centre.
The ﬁndings also indicate that, due to the increasingly ﬂexible approach to haemophilia
treatment in the U.K., adherence to prophylaxis is diﬃcult to deﬁne and assess. HPs agreed
that they often prioritise working with patients who are clearly struggling, as indicated by
bleeding episodes or other haemophilia-related issues they present with. This is partial
because they have to prioritise due to limited resources and time, but also because patients
who are not bleeding are often assumed to be doing well, even if they are not adhering to
their treatment or feel unable to pursue particular activities for fear of bleeding.
The ﬁndings of this research suggest that it may be useful to shift the focus of future
research away from looking for ways to improve adherence generally, but rather to
focus on improving adherence among those patients who are likely to have worse out-
comes due to sub-optimal adherence. It would be useful for the haemophilia healthcare
community to discuss adherence in this wider perspective, to come to a nationwide agree-
ment of what good adherence looks like in the context of improving outcomes in this
patients group.
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Conclusion
The increasingly ﬂexible approach to prophylaxis requires a new way of thinking about,
and assessment of, adherence. More personalised treatment plans can be more compli-
cated and can, therefore, lead to confusion and result in accidental non-adherence.
Some additional training and education of patients and their families are likely to
reduce this confusion, and therefore prevent accidental non-adherence. HPs felt quite
strongly that patients would beneﬁt from ongoing routine psychological support, ideally
provided by a psychologist who is a member of the haemophilia team. This would
allow the team to identify potential issues earlier and address these before they escalate,
and would make it much easier for patients to access support when they need it.
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